Venture Capital

BioInnovation Institute

Investment Details

Investor Type
Venture Capital

Asset Class Focus
Private Equity, Venture Capital

Stage Focus
Seed, Early Stage, Growth

Geographical Focus
United States, United Kingdom, Canada, Germany, Japan, Australia, Singapore, China, India, Brazil, France, Denmark, Switzerland, South Korea, Netherlands, Sweden, Belgium, Israel, Norway, Finland

Industries Focus

  • Pharmaceuticals
  • Medical Devices
  • Diagnostics
  • Biotechnology
  • Health Tech
  • Medical Research
  • Therapeutics
  • Immunology
  • Genomics
  • Women's Health
  • Bioindustrials
  • Quantum Technologies
  • Biomanufacturing
  • Data Security

Investment Size:
500,000 to 1,300,000 USD

Investor Details Founded: 2018

BioInnovation Institute (BII) is an international non-profit foundation based in Copenhagen, Denmark, dedicated to accelerating world-class life science innovation. Established in 2018, BII operates as a venture capital firm and incubator, focusing on early-stage start-ups that aim to improve human and planetary health. The institute offers a comprehensive suite of services, including funding, state-of-the-art laboratory and office facilities, business development support, and access to a global network of mentors and advisors. BII's programs, such as the Venture Lab and Venture House, provide founder-friendly convertible loans and strategic guidance to help start-ups navigate the challenges of commercialization and scale-up. Since its inception, BII has supported numerous companies across various sectors, including therapeutics, bioindustrials, and health tech, contributing to the growth and success of the life science ecosystem in Denmark and beyond.

Requirements
  • Early-stage life science start-ups
  • Focus on human and planetary health
  • Innovative solutions in therapeutics, bioindustrials, or health tech
Contact

[Official Website Hidden]

[LinkedIn Profile Hidden]

[HQ Location Hidden]

[Email Hidden]

[Contact Number Hidden]

Portfolio Companies
  • Embark Laboratories
  • Adcendo
  • STipe Therapeutics
  • Twelve Bio
  • Octarine Bio
  • Cirqle Biomedical
  • Glaze Life Sciences
  • DiaSense
  • Sqale
  • Alea Quantum Technologies
  • Solid Therapeutics
  • FimmCyte
  • Amplify Therapeutics
Claim this Investor

Are you an official representative of BioInnovation Institute?

Claim this investor to update information, manage your profile, and get a verified seal.

Claim